Cargando…

Bilateral Choroidal Detachment Induced by Unilateral Application of a Fixed Combination of Topical Timolol Maleate and Brinzolamide

We describe a 66-year-old man who developed bilateral choroidal detachment that was induced by unilateral topical administration of a fixed combination of 1% brinzolamide and 0.5% timolol maleate the day after an uneventful phacoemulsification surgery and intraocular lens implantation involving his...

Descripción completa

Detalles Bibliográficos
Autores principales:	DONMEZ, Oya, KILINC, Hilal, OZBEK, Zeynep, SAATCI, Ali Osman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medical Hypothesis, Discovery & Innovation Ophthalmology 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346301/ https://www.ncbi.nlm.nih.gov/pubmed/28293659

Ejemplares similares

Safety and Efficacy of Adding Fixed-Combination Brinzolamide/Timolol Maleate to Prostaglandin Therapy for Treatment of Ocular Hypertension or Glaucoma
por: Hommer, Anton, et al.
Publicado: (2015)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
por: Inoue, Kenji, et al.
Publicado: (2015)

Brinzolamide/timolol versus dorzolamide/timolol fixed combinations: A hospital-based, prospective, randomized study
por: Galose, Mary S, et al.
Publicado: (2016)

Effect of dacryocystorhinostomy on systemic adverse effects of topical timolol maleate
por: Roy, Kakoli, et al.
Publicado: (2012)

Sick sinus syndrome associated with topical timolol maleate instillation
por: Walia, Harpreet S., et al.
Publicado: (2011)

Topical timolol maleate: An effectual and safe recourse for infantile hemangiomas
por: Bhat, Yasmeen Jabeen, et al.
Publicado: (2016)

Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension
por: Yoshikawa, Keiji, et al.
Publicado: (2014)

Efficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practice
por: Lanzl, Ines, et al.
Publicado: (2011)

The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies
por: Radcliffe, Nathan M
Publicado: (2014)

Unilateral, recurrent exudative retinal detachment in association with pansinusitis
por: Osman Saatci, Ali, et al.
Publicado: (2012)

Preference for a fixed combination of brinzolamide/timolol versus dorzolamide/timolol among patients with open-angle glaucoma or ocular hypertension
por: Sanseau, Ana, et al.
Publicado: (2013)

Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension [Erratum]
Publicado: (2014)

Efficacy and Tolerability of Fixed-Combination Brinzolamide/Timolol in Latin American Patients with Open-Angle Glaucoma or Ocular Hypertension Previously on Brimonidine/Timolol Fixed Combination
por: Alezzandrini, Arturo, et al.
Publicado: (2014)

Comment on “Effect of dacryocystorhinostomy on systemic adverse effects of topical timolol maleate”
por: Arunachalam, Cynthia
Publicado: (2013)

Brinzolamide-timolol suspension: acceptability and side effect profile
por: Doherty, MD, et al.
Publicado: (2011)

Randomized trial comparing three fixed combinations of prostaglandins/prostamide with timolol maleate
por: Kelly Rigollet, Jaime Pablo, et al.
Publicado: (2011)

Update and optimal use of a brinzolamide-timolol fixed combination in open-angle glaucoma and ocular hypertension
por: Syed, Misha F, et al.
Publicado: (2011)

Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension
por: Lerner, S Fabián, et al.
Publicado: (2019)

A patient preference comparison of Azarga(™) (brinzolamide/timolol fixed combination) vs Cosopt(®) (dorzolamide/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension
por: Mundorf, Thomas K, et al.
Publicado: (2008)

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma
por: Wu, Hai Wei, et al.
Publicado: (2017)

Addition of a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension
por: Lorenz, Katrin, et al.
Publicado: (2011)

Optimization of Thermoreversible In Situ Nasal Gel of Timolol Maleate
por: Jagdale, Swati, et al.
Publicado: (2016)

Efficacy of Topical Brinzolamide Treatment in Posterior Microphthalmos- Related Macular Cystoid Lesions: A Case Series
por: Durmaz Engin, Ceren, et al.
Publicado: (2020)

Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin‐treated glaucoma patients
por: Aihara, Makoto, et al.
Publicado: (2017)

Conjunctival changes and inflammatory aspects in rabbits' conjunctivas induced by fixed combinations of prostaglandin analogues and timolol maleate
por: de Faria, Nubia Vanessa Lima, et al.
Publicado: (2013)

Evaluation of the Use of Brinzolamide-Brimonidine Fixed Combination in Maximum Medical Therapy
por: Tekeli, Oya, et al.
Publicado: (2022)

Safety and efficacy of a fixed versus unfixed brinzolamide/timolol combination in Japanese patients with open-angle glaucoma or ocular hypertension
por: Nagayama, Mikio, et al.
Publicado: (2014)

Patient perspectives when switching from Cosopt(®) (dorzolamide-timolol) to Azarga™ (brinzolamide-timolol) for glaucoma requiring multiple drug therapy
por: Auger, Graham Anthony, et al.
Publicado: (2012)

Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
por: Beckers, Henny JM, et al.
Publicado: (2009)

A comparative study on efficacy of fixed combination timolol/brinzolamide versus travoprost monotherapy in drug-naïve open-angle glaucoma patients
por: Dixit, Alok, et al.
Publicado: (2020)

Evaluation of the efficacy and safety of topical timolol maleate combined with oral propranolol treatment for parotid mixed infantile hemangiomas
por: Tong, Shuang, et al.
Publicado: (2016)

Infantile Hemangiomas with Minimal and Arrested Growth: Clinical Features and Treatment Outcomes with 0.5% Topical Timolol Maleate
por: Bae, Kyung-Nam, et al.
Publicado: (2021)

Magnesium Hydroxide Nanoparticles Improve the Ocular Hypotensive Effect of Twice Daily Topical Timolol Maleate in Healthy Dogs
por: Kita, Mizuki, et al.
Publicado: (2021)

Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial
por: Russ, Heloisa Helena, et al.
Publicado: (2013)

Polymeric ocular hydrogels and ophthalmic inserts for controlled release of timolol maleate
por: Singh, Vinod, et al.
Publicado: (2011)

Safety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from prior mono- or adjunctive therapy
por: Pfeiffer, Norbert, et al.
Publicado: (2010)

Comparative study to assess efficacy and safety of brinzolamide1% and timolol0.5% fixed combination eye drops versus dorzolamide2% and timolol0.5% fixed combination eye drops in management of open-angle glaucoma
por: Agarwal, Prerana, et al.
Publicado: (2022)

Comparing the Effectiveness and Adherence between Fixed and Non-Fixed Dorzolamide/Timolol Maleate in Open-Angle Glaucoma Patients in Hospital Universiti Sains Malaysia
por: Rasid, Noor-Khairul, et al.
Publicado: (2023)

Phase III safety and efficacy study of long-term brinzolamide/timolol fixed combination in Japanese patients with open-angle glaucoma or ocular hypertension
por: Nakajima, Masayuki, et al.
Publicado: (2014)

Brinzolamide 1%/timolol versus dorzolamide 2%/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study
por: Altafini, Romeo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cuds3i9m41lqtngj4hd9amsh76